Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/81115
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Health Technology and Informatics-
dc.creatorMitu, FS-
dc.creatorAl Maruf, MA-
dc.creatorMahanty, A-
dc.creatorHuda, AKMN-
dc.creatorKhan, SA-
dc.creatorRahman, MM-
dc.date.accessioned2019-07-29T03:18:02Z-
dc.date.available2019-07-29T03:18:02Z-
dc.identifier.issn1823-8262-
dc.identifier.urihttp://hdl.handle.net/10397/81115-
dc.language.isoenen_US
dc.publisherMalaysian Society for Microbiologyen_US
dc.rightsThis work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/).en_US
dc.rightsThe following publication Mitu, F. S., Al Maruf, M. A., Mahanty, A., Huda, A. K. M. N, Khan, S. A., … & Rahman, M. M. (2019). Prevalence of extended spectrum beta-lactamase (ESBL) and AmpC beta-lactamase producing bacteria in urinary tract infection patients in Bangladesh. Malaysian journal of microbiology, 15(3), 204-212 is available at https://dx.doi.org/10.21161/mjm.180193en_US
dc.subjectUrinary tract infectionen_US
dc.subjectESBLen_US
dc.subjectBacteriaen_US
dc.subjectAntibiotic resistanceen_US
dc.titlePrevalence of extended spectrum beta-lactamase (ESBL) and AmpC beta-lactamase producing bacteria in urinary tract infection patients in Bangladeshen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage204-
dc.identifier.epage212-
dc.identifier.volume15-
dc.identifier.issue3-
dc.identifier.doi10.21161/mjm.180193-
dcterms.abstractAims: This study aimed to determine the prevalence of pathogens in urinary tract and their antimicrobial susceptibilities, based on extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase production in Bangladesh.-
dcterms.abstractMethodology and results: The prevalence of pathogenic microorganisms in urinary tract and their antimicrobial resistance patterns were identified in 200 isolates from patients with urinary tract infections. Combined disc diffusion was performed to identify the presence of ESBL-producing strains. Moreover, disc approximation assay, disc potentiation test and double disc synergy test were performed to determine the presence of AmpC beta-lactamase producing bacterial strains. This study demonstrated a higher prevalence of UTIs in females (83.5%) than in males (16.5%). The most common pathogen was found Escherichia coli (44.5%), followed by Enterococcus fecalis (24%), Klebsiella pneumoniae (7.5%), Staphylococcus aureus (6%), Pseudomonas aeruginosa (5.5%) and Staphylococcus saprophyticus (4.5%). ESBL and AmpC beta-lactamase production occurred more frequently in E. coli (25.84%) and P. aeruginosa (100%) respectively.-
dcterms.abstractConclusion, significance and impact of study: The result of this study would provide physicians with important information which help them to make a judicious choice of antibiotics for therapeutic purposes. However, it is emphasized that continuous surveillance of antibiogram of medically important organisms causing UTI is necessary for adopting a rational antibiotic policy in the country.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationMalaysian journal of microbiology, 2019, v. 15, no. 3, p. 204-212-
dcterms.isPartOfMalaysian journal of microbiology-
dcterms.issued2019-
dc.identifier.isiWOS:000470091400005-
dc.identifier.eissn2231-7538-
dc.description.validate201907 bcrc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Mitu_Extended_Beta-lactamase_AmpC.pdf265.02 kBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

126
Citations as of Jul 3, 2022

Downloads

93
Citations as of Jul 3, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.